RxDoctor Payments Data

Ali Sorrell

Family · Lebanon, TNNPI 1003479601

Payments from drug & device makers

$3,043in general payments, 2019–2025

Across 172 payments — averaging $17.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$540
  • AstraZeneca$507
  • AbbVie$349
  • Lilly USA, LLC$247
  • Cequr Corporation$160
  • Corcept Therapeutics$122
  • plus $1K from 25 others

What the payments were for

  • Food & beverage$3,043100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,043 in reported general payments places this provider in the 80th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide21$21,720
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine42$1,364
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen14$599
Rosuvastatin Calcium45$343
Lisinopril44$294
Tamsulosin Hcl12$280
Colchicine12$267
Omeprazole20$250
Atorvastatin Calcium34$241
Pantoprazole Sodium22$238
Paroxetine Hcl21$235
Zolpidem Tartrate23$198
Alprazolam25$195
Losartan Potassium24$185
Clonazepam20$180

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$247$21,72021 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$17$17135 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 6,706 family providers in Tennessee.

Other family in Lebanon

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →